Verdant Labs Ships VerdantNode: The First Consumer Bioreactor That Grows Protein in Your Kitchen

SEATTLE — Verdant Labs, a biotech consumer hardware startup founded in 2025, has officially begun shipping VerdantNode, the world's first consumer-grade bioreactor designed for home kitchens. The device — priced at $499 with a $29/month nutrient cartridge subscription — produces 200 grams of complete, bioavailable protein daily through a proprietary engineered mycelium cultivation system.

The announcement comes after a 14-month beta program with 2,400 households across Seattle, Austin, and Singapore.

What It Actually Does

VerdantNode is not a supplement. It is a living cultivation system. Users load a sealed growth chamber with a sterile nutrient substrate — supplied in monthly cartridges — and the device's internal environmental controls (temperature, humidity, CO₂ concentration, and light spectrum) manage the growth cycle of Verdant Labs' proprietary fungal strain, VF-7.

VF-7 is an Ophiocordyceps sinensis x Pleurotus ostreatus hybrid, engineered via CRISPR to produce a complete amino acid profile equivalent to whey protein (PDCAAS score: 1.0) while containing zero cholesterol and reduced purines compared to animal protein. The resulting biomass has a neutral umami flavor designed to blend seamlessly into smoothies, soups, or baked goods.

A single growth cycle takes 38 hours from inoculation to harvest, producing approximately 200g of wet biomass (~45g dry protein). The sealed chamber processes continuously — users can harvest daily while simultaneously inoculating the next batch.

The App: VerdantOS

Each VerdantNode ships with VerdantOS, a companion iOS/Android app that monitors the growth chamber in real time via an array of internal sensors (pH, dissolved oxygen, optical density, and thermal cameras). The app:

• Alerts users when a harvest is ready via push notification
• Tracks cumulative protein production and estimates replacement value vs. purchasing equivalent whey protein
• Orders replacement nutrient cartridges automatically when supplies run low
• Adjusts the nutrient profile of the substrate cartridge to alter the final biomass's micronutrient composition (e.g., higher iron, added Vitamin D2)

The Science: Why Mycelium?

Verdant Labs chose mycelium over competing consumer protein platforms (insect cultivation, algae bioreactors) for three reasons: taste neutrality, rapid growth cycle, and low allergenicity. VF-7 is gluten-free, soy-free, and contains no common allergens. The fermentation process also generates natural B-vitamins, including B12 in a bioavailable form — a rarity in plant-based proteins.

The company's IP portfolio includes 23 patents covering the VF-7 strain, the sealed growth chamber aeration system, and the nutrient cartridge formulation.

Market Context

Verdant Labs is entering a consumer protein market valued at $48 billion globally in 2027. The startup positions VerdantNode as a direct replacement for whey protein powder — currently used by an estimated 180 million people worldwide — with a lower per-serve cost after 6 months of ownership ($0.34/gram of protein vs. $0.61/gram for premium whey).

The company reports a waitlist of 187,000 customers and plans to produce 50,000 units in its first manufacturing run. Retail availability at Best Buy and Amazon is targeted for Q1 2028.

Sustainability Claims

Verdant Labs claims VerdantNode uses 94% less water than equivalent animal protein production and zero land compared to conventional agriculture. Each nutrient cartridge is compostable (certified by the Biodegradable Products Institute) and ships in recycled pulp packaging. The company is pursuing Carbon Neutral certification from the Carbon Trust, expected by Q4 2028.

Funding

Verdant Labs has raised $127 million to date across three rounds, led by Lowercarbon Capital and Breakthrough Energy Ventures, with participation from Y Combinator and a consortium of angel investors from the food tech sector.